242
Participants
Start Date
February 27, 2025
Primary Completion Date
August 31, 2029
Study Completion Date
August 31, 2029
Gocatamig
IV infusion
Ifinatamab Deruxtecan (I-DXd)
IV infusion
Durvalumab
IV infusion
RECRUITING
Princess Alexandra Hospital ( Site 5300), Wooloongabba
RECRUITING
Roswell Park Cancer Institute ( Site 1107), Buffalo
RECRUITING
Hospital Clinico San Carlos... ( Site 3316), Madrid
RECRUITING
Hospital Universitario Fundación Jiménez Díaz-START Madrid-FJD ( Site 3315), Madrid
RECRUITING
Hospital Universitario HM Sanchinarro ( Site 3313), Madrid
RECRUITING
Hospital Universitario Virgen de la Victoria ( Site 3312), Málaga
RECRUITING
University of Miami Hospital and Clinics, Sylvester Cancer Center ( Site 1111), Miami
RECRUITING
Sarah Cannon Research Institute ( Site 7001), Nashville
RECRUITING
University of Chicago ( Site 1108), Chicago
RECRUITING
Providence Portland Medical Center ( Site 1101), Portland
RECRUITING
Rambam Health Care Campus ( Site 3202), Haifa
RECRUITING
Sheba Medical Center ( Site 3201), Ramat Gan
RECRUITING
FALP ( Site 2100), Santiago
RECRUITING
Bradfordhill ( Site 2101), Santiago
RECRUITING
Shaare Zedek Medical Center ( Site 3200), Jerusalem
RECRUITING
Dana Farber Cancer Institute ( Site 1105), Boston
RECRUITING
John Theurer Cancer Center at Hackensack University Medical Center ( Site 1103), Hackensack
RECRUITING
Aichi Cancer Center ( Site 5000), Nagoya
RECRUITING
National Cancer Center Hospital East ( Site 5001), Kashiwa
RECRUITING
Kansai Medical University Hospital ( Site 5004), Hirakata
RECRUITING
Cancer Institute Hospital of JFCR ( Site 5002), Koto
RECRUITING
Seoul National University Hospital ( Site 5100), Seoul
RECRUITING
Samsung Medical Center ( Site 5101), Seoul
RECRUITING
HOSPITAL CLÍNIC DE BARCELONA ( Site 3310), Eixample
RECRUITING
Institut Català d'Oncologia - L'Hospitalet ( Site 3317), L'Hospitalet de Llobregat
RECRUITING
Hospital Universitari Vall d'Hebron ( Site 3311), Barcelona
RECRUITING
Hacettepe Universite Hastaneleri ( Site 3410), Ankara
RECRUITING
Ankara Bilkent Sehir Hastanesi ( Site 3412), Ankara
Collaborators (1)
Daiichi Sankyo
INDUSTRY
Merck Sharp & Dohme LLC
INDUSTRY